Radar > 330764

ArchiMed in talks to acquire Suanfarma for EUR 550m

ArchiMed negociaría la adquisición de Suanfarma por EUR 550m

Intel ID : 330764

Intel ID 330764
Value EUR 550,00m (Approx.)
Native Currency Euro (EUR)
Financial Data - Suanfarma
(31 Dec 2022)
Revenue: EUR 92,43m
EBITDA: EUR 1,97m
Net Debt: EUR 722,88m
People: 31
Date
Country
Geography
Subsector (Old TTR Sectors)
Type
Intel Grade
Source
Tags

Bidder

Name
potential
Subsector (Old TTR Sectors)
Services and Distribution / Financial and Insurance (Primary)
Primary Sector (TTRSC)
25.01.09 Private Equity
25 Financial Services / 25.01 Banking & Investment

Country
Website
Description

Target

Name
potential
Subsector (Old TTR Sectors)
Industry / Pharmaceutical, Parapharmaceutical and Cosmetics (Primary)
Technology and Telecoms / Biotechnology
Primary Sector (TTRSC)
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Secondary Sectors (TTRSC)
30.02.03 Healthcare Product Distributors
30 Healthcare / 30.02 Healthcare Equipment & Supplies

Country
Website
Description

Seller

Name
potential
Subsector (Old TTR Sectors)
Services and Distribution / Financial and Insurance (Primary)
Primary Sector (TTRSC)
25.01.09 Private Equity
25 Financial Services / 25.01 Banking & Investment

Country
Website
Description

Seller

Name
potential
Subsector (Old TTR Sectors)
Services and Distribution / Financial and Insurance (Primary)
Primary Sector (TTRSC)
25.01.09 Private Equity
25 Financial Services / 25.01 Banking & Investment

Secondary Sectors (TTRSC)
25.01.10 Venture Capital
25 Financial Services / 25.01 Banking & Investment

Country
Website
Description

Mergers & Acquisitions

Date Target Country Buyer Seller VALUE (EURm) Subsector    

Legend:

verified Verified: Confirmed as a party to an active or possible transaction.

potential Potential: Unconfirmed as a party to an active or possible transaction.

retained Retained: Confirmed as “Retained” with a general or specific mandate.

prospect Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.

Transactional data is continuously updated by the research team and therefore is subject to change.